Composing Programming Languages by Combining Action-Semantics Modules

This article demonstrates a method for composing a programming language by combining action-semantics modules. Each module is defined separately, and then a programming-language module is defined by combining existing modules. This method enables the language designer to gradually develop a language by defining, selecting and combining suitable modules. The resulting modular structure is substantially different from that previously employed in action-semantic descriptions. It also discusses how to resolve the conflicts that may arise when combining modules, and indicates some advantages that action semantics has over other approaches in this respect

Wave Modeling of Infrastructure Modifications at Faleasao Harbor in American Samoa

Source: ICHE Conference Archive - https://mdi-de.baw.de/icheArchive

Implementation of a herd management system with wireless sensor networks

This paper investigates an adaptation of Wireless Sensor Networks (WSNs) to cattle monitoring applications. The proposed solution facilitates the requirement for continuously assessing the condition of individual animals, aggregating and reporting this data to the farm manager. There are several existing approaches to achieving animal monitoring, ranging from using a store and forward mechanism to employing GSM-based techniques; these approaches only provide sporadic information and introduce a considerable cost in staffing and physical hardware. The core of this study is to overcome the aforementioned drawbacks by using alternative cheap, low power consumption sensor nodes capable of providing real-time communication at a reasonable hardware cost. In this paper, both the hardware and software has been designed to provide a solution which can obtain real-time data from dairy cattle whilst conforming to the limitations associated with WSNs implementations

Expression of Lewis‐a glycans on polymorphonuclear leukocytes augments function by increasing transmigration

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141391/1/jlb0753.pd

Pengaruh Ketinggian Perangkap Feromon terhadap Penggerek Buah Kakao Conopomorpha cramerella Snell. (Lepidoptera: Gracillaridae)

Hama penggerek buah kakao/PBK (Conopomorpha cramerella Snell.) merupakan salah satu hama yang pada tingkat serangan berat dapat mengakibatkan kehilangan hasil kakao mencapai 90%. Penelitian ini bertujuan untuk menguji teknologi pengendalian hama PBK yang ramah lingkungan yaitu penggunaan perangkap feromon seks pada aspek posisi ketinggian perangkap yang efektif. Penelitian dilaksanakan di desa Banda Lama, Kecamatan Amahai, Kabupaten Maluku Tengah yang berlangsung dari bulan Januari sampai Maret 2019. Penelitian ini menguji ketinggian perangkap feromon pada tiga posisi ketinggian perangkap feromon yang berbeda yaitu ketinggian 1 m, 2 m dan 3 m. Data yang diambil adalah jumlah tangkapan imago C. cramerella tiap perlakuan. Hasil penelitian menunjukkan bahwa perangkap feromon dengan ketinggian 1 m yang paling efektif memerangkap hama PBK dengan jumlah tangkapan 85 ekor dan rerata populasi imago terperangkap adalah 10,63 ekor/bulan

Lattice instabilities of cubic NiTi from first principles

The phonon dispersion relation of NiTi in the simple cubic B2 structure is computed using first-principles density-functional perturbation theory with pseudopotentials and a plane-wave basis set. Lattice instabilities are observed to occur across nearly the entire Brillouin zone, excluding three interpenetrating tubes of stability along the (001) directions and small spheres of stability centered at R. The strongest instability is that of the doubly degenerate M5' mode. The atomic displacements of one of the eigenvectors of this mode generate a good approximation to the observed B19' ground-state structure.Comment: 11 pages, 3 figure

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study

Background: Mantle-cell lymphoma is an aggressive B-cell lymphoma with a poor prognosis. Both ibrutinib and temsirolimus have shown single-agent activity in patients with relapsed or refractory mantle-cell lymphoma. We undertook a phase 3 study to assess the efficacy and safety of ibrutinib versus temsirolimus in relapsed or refractory mantle-cell lymphoma. Methods: This randomised, open-label, multicentre, phase 3 clinical trial enrolled patients with relapsed or refractory mantle-cell lymphoma confirmed by central pathology in 21 countries who had received one or more rituximab-containing treatments. Patients were stratified by previous therapy and simplified mantle-cell lymphoma international prognostic index score, and were randomly assigned with a computer-generated randomisation schedule to receive daily oral ibrutinib 560 mg or intravenous temsirolimus (175 mg on days 1, 8, and 15 of cycle 1; 75 mg on days 1, 8, and 15 of subsequent 21-day cycles). Randomisation was balanced by using randomly permuted blocks. The primary efficacy endpoint was progression-free survival assessed by a masked independent review committee with the primary hypothesis that ibrutinib compared with temsirolimus significantly improves progression-free survival. The analysis followed the intention-to-treat principle. The trial is ongoing and is registered with ClinicalTrials.gov (number NCT01646021) and with the EU Clinical Trials Register, EudraCT (number 2012-000601-74). Findings: Between Dec 10, 2012, and Nov 26, 2013, 280 patients were randomised to ibrutinib (n=139) or temsirolimus (n=141). Primary efficacy analysis showed significant improvement in progression-free survival (p<0.0001) for patients treated with ibrutinib versus temsirolimus (hazard ratio 0.43 [95% CI 0.32-0.58]; median progression-free survival 14.6 months [95% CI 10.4-not estimable] vs 6.2 months [4.2-7.9], respectively). Ibrutinib was better tolerated than temsirolimus, with grade 3 or higher treatment-emergent adverse events reported for 94 (68%) versus 121 (87%) patients, and fewer discontinuations of study medication due to adverse events for ibrutinib versus temsirolimus (9 [6%] vs 36 [26%]). Interpretation: Ibrutinib treatment resulted in significant improvement in progression-free survival and better tolerability versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma. These data lend further support to the positive benefit-risk ratio for ibrutinib in relapsed or refractory mantle-cell lymphoma

Stromal mesenchyme cell genes of the human prostate and bladder

BACKGROUND: Stromal mesenchyme cells play an important role in epithelial differentiation and likely in cancer as well. Induction of epithelial differentiation is organ-specific, and the genes responsible could be identified through a comparative genomic analysis of the stromal cells from two different organs. These genes might be aberrantly expressed in cancer since cancer could be viewed as due to a defect in stromal signaling. We propose to identify the prostate stromal genes by analysis of differentially expressed genes between prostate and bladder stromal cells, and to examine their expression in prostate cancer. METHODS: Immunohistochemistry using antibodies to cluster designation (CD) cell surface antigens was first used to characterize the stromas of the prostate and bladder. Stromal cells were prepared from either prostate or bladder tissue for cell culture. RNA was isolated from the cultured cells and analyzed by DNA microarrays. Expression of candidate genes in normal prostate and prostate cancer was examined by RT-PCR. RESULTS: The bladder stroma was phenotypically different from that of the prostate. Most notable was the presence of a layer of CD13(+ )cells adjacent to the urothelium. This structural feature was also seen in the mouse bladder. The prostate stroma was uniformly CD13(-). A number of differentially expressed genes between prostate and bladder stromal cells were identified. One prostate gene, proenkephalin (PENK), was of interest because it encodes a hormone. Secreted proteins such as hormones and bioactive peptides are known to mediate cell-cell signaling. Prostate stromal expression of PENK was verified by an antibody raised against a PENK peptide, by RT-PCR analysis of laser-capture microdissected stromal cells, and by database analysis. Gene expression analysis showed that PENK expression was down-regulated in prostate cancer. CONCLUSION: Our findings show that the histologically similar stromas of the prostate and bladder are phenotypically different, and express organ-specific genes. The importance of these genes in epithelial development is suggested by their abnormal expression in cancer. Among the candidates is the hormone PENK and the down-regulation of PENK expression in cancer suggests a possible association with cancer development